• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT AFP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT AFP Back to Search Results
Catalog Number 03P36-30
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
The customer reports a falsely elevated architect afp assay result for one patient serum sample generated on an architect i2000sr analyzer.The patient was scheduled for the repair of an adult inguinal hernia.As part of the pre-operation screening, an architect afp was ordered and generated an initial result of 1376 ug/ml and questioned by physicians.An ultrasound and ct scan were performed and showed no abnormalities.Other tumor markers were negative.The sample retested at 2 ug/ml.Additional samples tested also generated a result of 2 ug/ml.There has been no impact to patient management reported other than the delay of the surgery.
 
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.(b)(4).(b)(6).
 
Manufacturer Narrative
An abbott field service representative visited the customer site and verified no issues with the architect (b)(4) analyzer.No customer returns were available for this evaluation.A review of architect afp complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation.The product evaluation did not include any testing of the suspect reagent lot 32152lf00 as re-testing of the patient sample by the customer consistently generated the expected lower result, which indicates that the customer issue is not reagent lot specific.A review of the manufacturing documentation did not identify any issues associated with the customer issue.The architect afp assay package insert and the architect (b)(4) operations manual both contain information to address the current customer issue.Based on a review of the information from the customer site and the results of the current evaluation, it was determined that the architect afp assay, lot 32152lf00, is performing as expected.A product malfunction was not identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT AFP
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
Manufacturer (Section G)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI   NA
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
847937-512
MDR Report Key3698427
MDR Text Key4250322
Report Number3008344661-2014-00016
Device Sequence Number1
Product Code LOK
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P120008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/25/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date08/14/2014
Device Catalogue Number03P36-30
Device Lot Number32152LF00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/28/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/05/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR LN:03M74-02 SN:(B)(4); ARCHITECT I2000SR LN:03M74-02 SN:(B)(4)
-
-